Pharmacometabolomics


The study of metabolites produced by the body and their quantification and analysis is known as metabolomics. Pharmacometabolomics is a branch of this discipline. It describes the precise measurement of metabolites in a person's physiological fluids, imagines or assesses how pharmaceutical chemicals are metabolised, and enhances comprehension of the pharmacokinetic profile of a medicine. Contrarily, pharmacometabolomics can be used to assess metabolite levels after a pharmacological substance has been administered in order to track the compound's effects on specific metabolic pathways. This gives a thorough picture of how drugs affect metabolism and the pathways that may play a role in the variability of treatment response. Additionally, the metabolic profile of a person at baseline reveals variation within a population health  and offers information about how people respond to treatment


    Related Conference of Pharmacometabolomics

    October 31-01, 2024

    8th International Conference on Internal Medicine

    Amsterdam, Netherlands
    November 22-23, 2024

    4th International Conference on Medical Research and Development

    Aix-en-Provence, France
    November 25-26, 2024

    10th World Congress on Anesthesia and Critical Care

    Paris, France
    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France

    Pharmacometabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in